Closed System Transfer Devices must be used for the administration of antineoplastic hazardous drugs when the dosage form allows.
The Q-FLO Connector is an advanced Closed System Transfer Device (CTSD) Technology designed to minimize the potential exposure to Hazardous Drugs (HD) used in Chemotherapy. The Q-FLO’s unique design allows the fluid path to be activated/deactivated while connected to a Needleless IV Access Port (attached Q-FLO technical datasheet)
The Q-FLO has been evaluated to meet the (National Institute for Occupational Safety and Health (NIOSH) definition of a Closed System Transfer Device through the testing protocol “A Vapor Containment Performance Protocol for Closed System Transfer Devices Used during Pharmacy Compounding and Administration of Hazardous Drugs”
In the current Clinical environment, millions of Healthcare Workers can be exposed to Hazardous Drugs (HD) during Preparation, Administration, and Disposal daily. The danger of exposure can range from skin rashes, infertility and miscarriage, to birth defects as well as Leukemia or other cancers.
Studies have shown (attach studies link) that traces of Hazardous Drugs (HD) have been detected in preparation, administration, and disposal areas as well as non-clinical areas such as waiting rooms and countertops.
In addition, the exposure of Healthcare Workers to these Hazardous Drugs (HD) has been detailed in studies (attach studies link) that have shown HD presence in Clinicians that have directly handled these drugs as well as Clinicians, Staff that has not directly handled those drugs.
Given these significant health risks Clinicians are facing, new regulations governing the handling of Hazardous Drugs that were published by the United States Pharmacopeial convention in 2016. These Guidelines, USP 800, were put into effect as of December 2019.
(Attach Q-FLO white paper), (NIOSH testing protocol article)